The QUEST trial aimed to investigate the effects of qiliqiangxin, a traditional Chinese Medicine formulation, in patients with heart failure with reduced ejection fraction (HFrEF).
Learn more about the interesting findings 👉cardiology-update.com
#qiliqiangxin #HFrEF #heartfailure #cardiologist #cardiology #cardiologyupdate
5 окт 2024
